These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 22144436

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacology of 8-aminoquinolines.
    Grewal RS.
    Bull World Health Organ; 1981; 59(3):397-406. PubMed ID: 6976847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of relapsing Plasmodium vivax malaria.
    Chu CS, White NJ.
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
    [Abstract] [Full Text] [Related]

  • 10. Radical curative activity of a new 8-aminoquinoline derivative (CDRI 80/53) against Plasmodium cynomolgi B in monkeys.
    Dutta GP, Puri SK, Bhaduri AP, Seth M.
    Am J Trop Med Hyg; 1989 Dec; 41(6):635-7. PubMed ID: 2641640
    [Abstract] [Full Text] [Related]

  • 11. Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence.
    Val F, Costa FT, King L, Brito-Sousa JD, Bassat Q, Monteiro WM, Siqueira AM, Luzzatto L, Lacerda MV.
    Future Microbiol; 2019 Oct; 14():1261-1279. PubMed ID: 31596137
    [Abstract] [Full Text] [Related]

  • 12. The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
    Peters W, Stewart LB, Robinson BL.
    Ann Trop Med Parasitol; 2003 Apr; 97(3):221-36. PubMed ID: 12803854
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
    Watson J, Taylor WRJ, Bancone G, Chu CS, Jittamala P, White NJ.
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
    [Abstract] [Full Text] [Related]

  • 17. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
    DiTusa C, Kozar MP, Pybus B, Sousa J, Berman J, Gettayacamin M, Im-erbsin R, Tungtaeng A, Ohrt C.
    J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
    [Abstract] [Full Text] [Related]

  • 18. Single dose tafenoquine for preventing relapse in people with plasmodium vivax malaria-an updated meta-analysis.
    Anjum MU, Naveed AK, Mahmood SN, Naveed OK.
    Travel Med Infect Dis; 2020 Oct; 36():101576. PubMed ID: 32036012
    [Abstract] [Full Text] [Related]

  • 19. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
    Graves PM, Choi L, Gelband H, Garner P.
    Cochrane Database Syst Rev; 2018 Feb 02; 2(2):CD008152. PubMed ID: 29393511
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.